DrugPatentWatch Database Preview

Pharmacia Company Profile

Email this page to a colleague

PHARMACIA has one hundred and thirty-two approved drugs.

There are seven US patents protecting PHARMACIA drugs.

There are two hundred and sixty-four patent family members on PHARMACIA drugs in fifty-one countries and sixty-five supplementary protection certificates in fourteen countries.

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Pharmacia And Upjohn	NEO-MEDROL ACETATE	methylprednisolone acetate; neomycin sulfate	CREAM;TOPICAL	060611-002	Approved Prior to Jan 1, 1982		DISCN	No	No		Start Trial				Start Trial
Pharmacia And Upjohn	U-GENCIN	gentamicin sulfate	INJECTABLE;INJECTION	062248-002	Approved Prior to Jan 1, 1982		DISCN	No	No		Start Trial				Start Trial
Pharmacia And Upjohn	TOLINASE	tolazamide	TABLET;ORAL	015500-005	Approved Prior to Jan 1, 1982		DISCN	Yes	No		Start Trial				Start Trial
Pharmacia And Upjohn	NEO-MEDROL	methylprednisolone; neomycin sulfate	OINTMENT;OPHTHALMIC	060645-001	Approved Prior to Jan 1, 1982		DISCN	No	No		Start Trial				Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Pharmacia And Upjohn	GLYNASE	glyburide	TABLET;ORAL	020051-001	Mar 4, 1992	3,507,954	Start Trial
Pharmacia And Upjohn	NICOTROL	nicotine	INHALANT;ORAL	020714-001	May 2, 1997	5,501,236	Start Trial
Pharmacia And Upjohn	MICRONASE	glyburide	TABLET;ORAL	017498-003	May 1, 1984	3,454,635	Start Trial
Pharmacia And Upjohn	MICRONASE	glyburide	TABLET;ORAL	017498-001	May 1, 1984	3,507,961	Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Drugname	Dosage	Strength	Tradename	Submissiondate
➤ Subscribe	Extended-release Capsules	2 mg and 4 mg	➤ Subscribe	2007-07-30
➤ Subscribe	Oral Suspension	100 mg/5 mL	➤ Subscribe	2009-08-03
➤ Subscribe	Injection	2 mg/mL, 100 mL bag	➤ Subscribe	2009-12-29
➤ Subscribe	Tablets	600 mg	➤ Subscribe	2005-12-21
➤ Subscribe	Injection	2 mg/mL, 300 mL bag	➤ Subscribe	2009-09-01
➤ Subscribe	Tablets	1 g	➤ Subscribe	2005-08-23

Subscribe to access the full database, or Start Trial
Patent Number	Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
0809498	10C0038	France	Start Trial	PRODUCT NAME: ACYCLOVIR ET HYDROCORTISONE; NAT. REGISTRATION NO/DATE: NL 36 826 20100420; FIRST REGISTRATION: SK - 2108/08467-R 20091026
0136011	2000C/027	Belgium	Start Trial	PRODUCT NAME: ETHINYLESTRADIOLUM / NORETHISTERONI ACETAS; NAT. REGISTRATION NO/DATE: 19 IS 106 F3 20000911; FIRST REGISTRATION: NL RVG 23909 19991124
0334429	97C0002	Belgium	Start Trial	PRODUCT NAME: ESTRADIOL; NAT. REGISTRATION NO/DATE: NL 18978 19960731; FIRST REGISTRATION: SE - 11783 19930305
0164865	C970030	Netherlands	Start Trial	PRODUCT NAME: IBUTILIDE, DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH AANVAARD BAAR ZOUT, IN HET BIJZONDER HET FUMARAAT; NAT. REGISTRATION NO/DATE: RVG 21286 19970612; FIRST REGISTRATION: GB PL 0032/0212 19960930
>Patent Number	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration	>SPC Description

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.